Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-26-016522
Filing Date
2026-03-10
Accepted
2026-03-10 16:55:11
Documents
97
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K espr-20251231.htm   iXBRL 10-K 2212909
2 EX-10.27 esperion-otsukaxfirstamend.htm EX-10.27 40166
3 EX-23.1 ex-231q42025.htm EX-23.1 11845
4 EX-31.1 ex-311q42025.htm EX-31.1 9768
5 EX-31.2 ex-312q42025.htm EX-31.2 10004
6 EX-32.1 ex-321q42025.htm EX-32.1 6139
12 GRAPHIC espr-20251231_g1.jpg GRAPHIC 592161
  Complete submission text file 0001628280-26-016522.txt   11667987

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20251231.xsd EX-101.SCH 82174
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20251231_cal.xml EX-101.CAL 96168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20251231_def.xml EX-101.DEF 366843
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20251231_lab.xml EX-101.LAB 968080
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20251231_pre.xml EX-101.PRE 655461
100 EXTRACTED XBRL INSTANCE DOCUMENT espr-20251231_htm.xml XML 1191833
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 26740160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)